Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Amgen reveals latest in inhibitors of matrix metalloproteinases

July 21, 1999

New Amgen compounds for disorders mediated by TNF-alpha, collagenase and/or stromelysin

July 20, 1999

MGI Pharma to copromote rheumatology product with Pharmacia & Upjohn

July 19, 1999

Inhibitors of caspases undergo joint development at Warner-Lambert and BASF

July 19, 1999

New label sought for Enbrel in early, active RA

July 16, 1999

AdProTech presents data on its membrane-active complement inhibitor

July 16, 1999

CSAID from Italfarmaco prevents de novo formation of B1 receptors

July 15, 1999

New series from Novo Nordisk useful for pain, inflammation, NIDDM, etc.

July 15, 1999

TT-232, a new somatostatin analogue, effective against neurogenic and non-neurogenic inflammation

July 14, 1999

Novel pyridazines from Kowa inhibit cytokine production

July 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...